左心室辅助器件患者的隔膜训练:对康复和临床影响的叙述性审查
Bruno Bordoni1, Bruno Morabito2, Allan R Escher3,4
1Physical Medicine and Rehabilitation, Foundation Don Carlo Gnocchi, Milan, ITA.
Cureus
|December 29, 2025
概括
本综述强调了腹膜康复的重要性,特别是鼓动肌肉训练 (IMT),在心脏康复 (CR) 计划中用于左心室辅助器件 (LVAD) 的患者. 结合IMT可以改善这些晚期心力衰竭患者的结果.
科学领域:
- 心脏病学 心脏病学
- 肺部康复治疗 肺部康复治疗
- 生物医学工程 生物医学工程
背景情况:
- 慢性心力衰竭 (HF) 影响全球数百万人,心脏移植 (HTx) 是末期病例的黄金标准.
- 越来越多的HF患者人口超过HTx的可用性,需要使用耐用左心室辅助装置 (LVAD) 等替代治疗方法.
- 心脏康复 (CR) 为LVAD患者提供了好处,但隔膜康复指导显著缺席.
研究的目的:
- 强调将启发性肌肉训练 (IMT) 纳入LVAD接受者的标准CR协议的关键需求.
- 审查LVAD技术的演变,重点关注HeartMate 3 (HM3) 设备.
- 讨论与LVAD和CR相关的病理生理学,不良事件和积极适应.
主要方法:
- 文献综述侧重于LVAD,心脏康复和启发性肌肉训练.
- 对HF和LVAD患者腹膜中的病理生理适应的分析.
- 检查与LVAD和CR相关的临床结果和不良事件.
主要成果:
- LVADs,特别是像HM3这样的新一代,对于等待或不符合HTx的末期HF患者来说,是重要的治疗选择.
- CR项目显示出显著的临床益处和改善了LVAD患者的生活质量.
- 在HF和LVAD患者中,隔膜经历了显著的病理生理变化,这强调了有针对性的康复的必要性.
结论:
- 鼓舞性肌肉训练 (IMT) 应该经常纳入心脏康复 (CR) 对于LVAD患者来解决隔膜功能障碍.
- 了解LVAD设备功能,不良事件和患者适应对于优化护理至关重要.
- 包括IMT在内的综合CR方法可以提高LVADs管理的晚期心力衰竭患者的康复和生活质量.
相关概念视频
Cardiomyopathy V: Interprofessional Care
310
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310
Cardiomyopathy II: Dilated Cardiomyopathy
431
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
431
Heart Failure VI: Adjunct Therapies
233
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
233
Mitral Stenosis IV: Nursing Management
234
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
234
Mitral Regurgitation IV: Nursing Management
286
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
286
Aortic Regurgitation III: Medical Management
366
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
366


